---
title: "贝伦贝格将礼来公司评级从 “买入” 下调至 “持有” 将目标价从 970 美元下调至 830 美元。"
description: "贝伦贝格将礼来公司评级从 “买入” 下调至 “持有” 将目标价从 970 美元下调至 830 美元。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/257654737.md"
published_at: "2025-09-17T05:08:11.000Z"
---

# 贝伦贝格将礼来公司评级从 “买入” 下调至 “持有” 将目标价从 970 美元下调至 830 美元。

贝伦贝格将礼来公司评级从 “买入” 下调至 “持有” 将目标价从 970 美元下调至 830 美元。

### Related Stocks

- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Eli Lilly (LLY) Builds $1.5 Billion Inventory of Weight-Loss Pill | Eli Lilly (LLY) has prepared a $1.5 billion inventory of its new weight-loss pill, Orforglipron, ahead of its anticipate | [Link](https://longbridge.com/zh-CN/news/276070062.md) |
| Eli Lilly and Company $LLY Shares Acquired by Assetmark Inc. | Assetmark Inc. increased its holdings in Eli Lilly and Company (NYSE: LLY) by 6.0% in Q3, owning 55,360 shares valued at | [Link](https://longbridge.com/zh-CN/news/275971336.md) |
| Broderick Brian C Purchases 985 Shares of Eli Lilly and Company $LLY | Broderick Brian C increased its stake in Eli Lilly and Company (NYSE: LLY) by 15.1% in Q3, acquiring 985 additional shar | [Link](https://longbridge.com/zh-CN/news/276435096.md) |
| Eli Lilly Breaks New Ground In Crohn's Disease Treatment | Eli Lilly (LLY) announced significant Phase 3 results for its Crohn's disease treatment, Omvoh, with over 90% of patient | [Link](https://longbridge.com/zh-CN/news/276442344.md) |
| Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients | Eli Lilly's Phase 3 LIBRETTO-432 trial for Retevmo (selpercatinib) shows significant reduction in recurrence risk for ea | [Link](https://longbridge.com/zh-CN/news/276119494.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。